Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical usefulness of human epidermal growth factor receptor-2 extracellular domain as a biomarker for monitoring cancer status and predicting the therapeutic efficacy in breast cancer.
Kontani K, Kuroda N, Hashimoto S, Murazawa C, Norimura S, Tanaka H, Ohtani M, Fujiwara-Honjo N, Kushida Y, Date M, Haba R, Houchi H, Yamauchi A, Yokomise H. Kontani K, et al. Cancer Biol Ther. 2013 Jan;14(1):20-8. doi: 10.4161/cbt.22626. Epub 2012 Oct 31. Cancer Biol Ther. 2013. PMID: 23114645 Free PMC article.
Factors responsible for long-term survival in metastatic breast cancer.
Kontani K, Hashimoto S, Murazawa C, Norimura S, Tanaka H, Ohtani M, Fujiwara-Honjo N, Date M, Teramoto K, Houchi H, Yokomise H. Kontani K, et al. World J Surg Oncol. 2014 Nov 14;12:344. doi: 10.1186/1477-7819-12-344. World J Surg Oncol. 2014. PMID: 25395387 Free PMC article.
Malposition of femoral venous cannulation.
Izuishi K, Hashimoto S, Uchinomura S, Usuki H, Masaki T, Maeta H. Izuishi K, et al. Am J Surg. 2005 Jan;189(1):47-8. doi: 10.1016/j.amjsurg.2004.04.010. Am J Surg. 2005. PMID: 15701490 No abstract available.
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
Kawajiri C, Tanaka H, Hashimoto S, Takeda Y, Sakai S, Takagi T, Takeuchi M, Ohwada C, Sakaida E, Shimizu N, Nakaseko C. Kawajiri C, et al. Int J Hematol. 2014 Apr;99(4):513-8. doi: 10.1007/s12185-014-1531-0. Epub 2014 Feb 15. Int J Hematol. 2014. PMID: 24532437
53 results